Bora manufactures more than 20 commercial products for GSK at
Partnership creates simplified pathway from early development to commercial launch
Milestone reflects the company’s continued impact in providing global pharmaceutical
MISSISSAUGA (October, 2025) — Bora Pharmaceuticals Co., Ltd. (“Bora” or
Leading CDMO selected amongst hundreds of worldwide nominations by Biotech
Isolator line provides U.S.-based fill/finish capacity for partners in oncology
Early 2026 launch of liquid-filled hard capsule capabilities will expand
Buildout includes Gerteis Macro-Pactor® install, with additional investments to follow,
Maple Grove, MN & Taipei, Taiwan – July 23, 2025
Cutting-Edge Technology to Accelerate High-Volume Production; Mississauga Site to be
